Search for Roche Holding AG and
    1. December 19, 2014

      Roche suffers double blow in drug trials

      Shares in Roche suffered their biggest one-day drop in five years on Friday after a double setback in trials of new drugs...

    2. December 10, 2014

      India assumes frontline position in battles over intellectual property rights

      As their cities grow more polluted, more people in India grapple with respiratory difficulties. The Swiss multinational...

    Special Reports

    1. Combating Cancer

      A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
    2. Innovation in Healthcare

      Healthcare has been slower than other industries to feel the full force of digital tec...
    Search more Special Reports on this topic.

    1. November 25, 2014

      Eurosceptic parties harm recovery, chief executives warn

      Chief executives at Europe’s largest companies have warned that rising support for eurosceptic political parties is...

    2. FT Alphaville

      October 29, 2014

      This is BABA, what's your target price? [updated]

      First on Alibaba, the FT reports that the Cayman registered derivative contract vaguely related to ecommerce in China — and...

    3. October 28, 2014

      Alibaba’s market value nudges Walmart

      Alibaba, the Chinese ecommerce behemoth that listed in New York last month, briefly muscled ahead of Walmart by one...

    4. October 16, 2014

      Roche sees sales of new cancer drugs rise

      Strong uptake of two of Roche’s new breast cancer drugs helped the Swiss drugmaker beat expectations in the third quarter....

    5. October 9, 2014

      The best in-house legal teams are coming up with revenue-generating ideas

      The annual publication of law firms’ fees and profits are an exciting event for partners. They use the infamous PEP (profits...

    6. September 26, 2014

      Drug development: Big pharma back in the game it made

      Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

    7. September 4, 2014

      Levinson move highlights Google health ambitions

      The man Google hopes will unlock the secrets of ageing has quit his board seat at Swiss drugs group Roche in a sign of the...

    8. August 25, 2014

      Roche: bets on discovery

      At one end of the pharma merger spectrum lies efficiency. Put two companies together and squeeze costs out. At the other...

    9. August 24, 2014

      Roche to buy InterMune for $8.3bn

      Roche has agreed to buy InterMune, the US biotech company, for $8.3bn in the latest example of the feverish deal activity...

    10. August 18, 2014

      Chugai shares soar on Roche buyout talk

      Shares in Japan’s Chugai Pharmaceutical soared to a record high on Monday on reports that Swiss drugmaker Roche was...

    11. August 18, 2014

      Roche / Chugai: uptown problems

      An uptown problem, if there ever was one: whatever to do with all that money. Roche has thrown off, on average, SFr12.6bn...

    12. Business Blog

      August 18, 2014

      Chugai and Roche: just good friends?

      The denial from Chugai Pharmaceutical could hardly have been more emphatic. No, Japan’s number three drugmaker by market...

    13. August 18, 2014

      Stocks advance as Ukraine worries ease

      Monday 21:00 BST. Global stocks started the week on a firm note amid easing concerns over the situation in Ukraine and a...

    14. August 15, 2014

      Roche to bid $10bn for full control of Japan’s Chugai

      Roche is set to offer $10bn to take full control of Japan’s Chugai Pharmaceuticals as the Swiss drugmaker looks to expand...

    15. August 8, 2014

      Roche clashes with UK watchdog on blocked cancer drug

      It has become a familiar dance: Britain’s drug costs watchdog rejects a new medicine as too expensive, prompting warnings...

    16. August 4, 2014

      Roche continues dealmaking with acquisition of Santaris

      Roche is to buy Santaris Pharma for up to $450m in the latest piece of dealmaking by the Swiss pharmaceuticals group. Roche...

    17. July 24, 2014

      Roche profit falls as writedown and strong Swiss franc hit group

      Roche posted a 7 per cent fall in net profit in the first half of the year, after the Swiss pharmaceuticals group was hit by...

    18. July 23, 2014

      Delta gains on domestic demand underpin

      Delta Air Lines lifted the US airline sector on Wednesday after it said results were underpinned by strong domestic demand,...

    19. July 16, 2014

      Eli Lilly joins forces with UK biotech to develop cancer drugs

      Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill cancer...

    20. July 2, 2014

      Roche to buy US cancer drug group Seragon

      Roche has agreed to buy Seragon Pharmaceuticals, a privately owned US biotech company, for up to $1.7bn, in a deal that...

    21. June 30, 2014

      Roche rebuts criticism of Tamiflu stockpiling

      Roche has hit back against what it termed a “seriously flawed” study that said the UK government had wasted almost £500m...

    22. June 2, 2014

      Roche to buy Genia of US for up to $350m

      Roche is to buy the US gene-sequencing company Genia in a deal that could cost up to $350m, as the Swiss pharmaceuticals...

    23. May 30, 2014

      Hopes for cancer cures offer comfort for battered pharma

      It is the Holy Grail of medical science. Ever since Hippocrates, the Greek physician, first described the disease more than...

    24. May 29, 2014

      Italian health ministry to seek €1.2bn from Roche and Novartis

      Italy’s health ministry said that it plans to seek damages of €1.2bn from Roche and Novartis after the Italian antitrust...

    25. May 23, 2014

      Chinese officials deny Roche visit was bribery-related

      Local government officials in the eastern Chinese city of Hangzhou on Friday denied that a visit this week to the local...

    26. April 15, 2014

      Roche drug boosts to revenue counteracted by currency’s strength

      Roche’s revenues fell 1 per cent in the first quarter as the strength of the Swiss franc weighed on the pharma group, even...

    27. April 11, 2014

      Big pharma: Storehouse of trouble

      Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and hosts...

    28. April 10, 2014

      French probe alleged drug collusion

      France’s competition authority is investigating Roche and Novartis over alleged collusion to protect one of their...

    29. March 26, 2014

      Kim Lim: Carvings, Roche Court, Wiltshire, UK – review

      Set amid lush Wiltshire countryside, the New Art Centre’s luminous gallery at Roche Court is an ideal setting for Kim Lim....

    30. March 13, 2014

      Lufthansa revives dividend as restructuring efforts take effect

      Lufthansa reinstated its dividend as the restructuring of its European network began to bear fruit; the German airline also...

    31. March 4, 2014

      Roche chairman fears for R&D amid squeeze on investment

      Europe risks losing investment in research and development because of the reluctance of cash-strapped governments to pay for...

    32. February 7, 2014

      Roche wins battle against India sales of generic cancer drug

      Two generic pharmaceutical companies have been ordered to stop selling their version of a Roche breast cancer treatment in...

    33. January 30, 2014

      Roche to lead way on corporate governance crackdown

      Roche will become one of the first big Swiss companies to implement tough new corporate governance rules designed to remove...

    34. January 29, 2014

      Novartis considers future of $14bn Roche stake

      Novartis’s $14bn stake in its local rival Roche is one of the assets it is scrutinising as part of a broader review of its...

    35. January 27, 2014

      Hepatitis C: Treated – at a price

      Gemma Peppe lived with hepatitis C for two decades before she – and the teenage son she inadvertently infected at birth –...

    36. January 8, 2014

      AstraZeneca strikes deal with UK’s Immunocore

      AstraZeneca has struck a deal with a fast-growing UK biotech company to develop treatments that use the body’s immune system...

    37. October 17, 2013

      Roche / Novartis: combination therapy

      Winter might be descending on the Alps, but spring is in the air in Basel. The Swiss city, home to Roche and Novartis, has...

    38. September 30, 2013

      Roche chief Severin Schwan open to co-operation with Novartis

      Roche’s chief executive has signalled openness to renewed co-operation with counterparts at his Swiss rival Novartis, in a...

    Search for Roche Holding AG and